These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12243078)

  • 1. [Prostatic cancer with multiple pulmonary metastases treated successfully with hormonal therapy: a case report].
    Fukuda M; Takashima H; Fuse H; Hirano S
    Hinyokika Kiyo; 2002 Aug; 48(8):499-502. PubMed ID: 12243078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report].
    Tokumitsu M; Inada F; Kitahara K; Kawakami N; Masui N; Ishida H; Ishida H; Saga Y; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 2001 Jan; 47(1):59-62. PubMed ID: 11235226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of prostatic cancer discovered from lung metastatic lesions].
    Segawa N; Abe H; Nishida T; Katsuoka Y
    Hinyokika Kiyo; 2006 Feb; 52(2):147-9. PubMed ID: 16541771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T; Campbell J; Bryant C; Lynch W
    Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of prostate cancer treated with combined androgen-blockade].
    Kurita M; Kato Y; Tamura Y; Suzuki K; Yamanaka H
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):307-10. PubMed ID: 10700907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
    Slovin SF
    Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
    Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
    Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostatic cancer with cystic formation: a case report].
    Kubo M; Taguchi K; Fujisue H; Ihara H; Ikoma F
    Hinyokika Kiyo; 1998 Dec; 44(12):883-6. PubMed ID: 10028435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study.
    Diamond TH; Winters J; Smith A; De Souza P; Kersley JH; Lynch WJ; Bryant C
    Cancer; 2001 Sep; 92(6):1444-50. PubMed ID: 11745221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
    Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
    Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer.
    Uehara S; Yuasa T; Fujii Y; Yano A; Yamamoto S; Masuda H; Fukui I; Yonese J
    BMC Res Notes; 2015 Aug; 8():335. PubMed ID: 26242866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer with multiple lung metastases in a hemodialysis patient.
    Hayakawa K; Matsumoto M; Aoyagi T; Miyaji K; Hata M
    Int J Urol; 2000 Dec; 7(12):464-6. PubMed ID: 11168686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ; Oh WK
    Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial.
    de Leval J; Boca P; Yousef E; Nicolas H; Jeukenne M; Seidel L; Bouffioux C; Coppens L; Bonnet P; Andrianne R; Wlatregny D
    Clin Prostate Cancer; 2002 Dec; 1(3):163-71. PubMed ID: 15046691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intermittent androgen deprivation treatment of prostate cancer restarted at low level of serum prostate specific antigen: a pilot study].
    Maekawa S; Maegawa M; Ushida H; Inoue K; Kaneko Y; Ohmori K; Nishimura K
    Hinyokika Kiyo; 2001 Aug; 47(8):553-5. PubMed ID: 11579594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamide.
    Cusan L; Gomez JL; Dupont A; Diamond P; Lemay M; Moore S; Labrie F
    Prostate; 1994 May; 24(5):257-61. PubMed ID: 7513417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of locally advanced prostate cancer with low serum testosterone associated with intake of an androgenic medicine].
    Sakura M; Tsukamoto T; Yonese J; Nakaishi M; Maezawa T; Takimoto K; Fukui I
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):529-32. PubMed ID: 12795169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital metastasis as a first indication of prostate cancer: a case report.
    Autorino R; Zito A; Di Giacomo F; Cosentino L; Quarto G; Di Lorenzo G; Mordente S; Pane U; Giordano A; D'Armiento M
    Arch Ital Urol Androl; 2005 Jun; 77(2):109-10. PubMed ID: 16146273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.
    Herrada J; Dieringer P; Logothetis CJ
    J Urol; 1996 Feb; 155(2):620-3. PubMed ID: 8558675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men.
    Egawa S; Takashima R; Matsumoto K; Mizoguchi H; Kuwao S; Baba S
    Jpn J Clin Oncol; 2000 Jan; 30(1):21-6. PubMed ID: 10770564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.